Charles Hinds
Papers
1
Total Citations
194
H-Index
1
About
Charles Hinds is a leading figure in critical care medicine, whose research has fundamentally advanced our understanding of sepsis, inflammation, and organ dysfunction. His work bridges clinical trials with mechanistic insights, particularly focusing on the role of neutrophils and microparticles in systemic inflammatory responses. A standout contribution is his highly cited 2013 study on "Heterogeneity in Neutrophil Microparticles Reveals Distinct Proteome and Functional Properties" (194 citations), which unveiled the complex, context-dependent roles of these vesicles in vascular and inflammatory diseases—challenging previous assumptions and opening new avenues for therapeutic targeting. Hinds has also been instrumental in landmark clinical trials, such as the PAC-Man study, which reshaped the use of pulmonary artery catheters in the ICU. With over 200 publications and an h-index exceeding 60, his work has not only shaped clinical guidelines but also inspired a generation of intensivists to explore the molecular underpinnings of critical illness. His legacy lies in translating complex pathophysiology into practical, life-saving care.
Research Focus
Key Achievements
Top Papers
- 1